Brett Hewlett - Comvita Insider

CVNZF -- USA Stock  

USD 5.99  0.00  0.00%

Mr. Brett Donald Hewlett serves as Independent Director of the Company. He was Chief Executive Officer of the Company., effective October 5, 2015. He is a current member of the New Zealand Trade and Enterprise Better by Design Advisory Board and an Independent Director of the USbased specialty medical device and pharmaceutical company Derma Sciences Inc. Brett holds significant international business development experience, including roles in emerging and developed markets. He previously served 15 years of a 20year career internationally with worldleading food packaging company, Tetra Pak. For five years he served as regional Managing Director of Tetra Paks eastern Mediterranean markets. Prior to that Brett worked as Commercial Director for Tetra Pak in Saudi Arabia and has also held other commercial and project management positions in the UK and Europe. He has run his own strategy consulting company and was an active angel investor supporting startup companies in New Zealand. Brett has a Bachelor of Food Technology degree from Massey University and a Masters of Business Administration from IMD in Switzerland.
Age: 51  CEO Since 2017      
64 7 533 1426

Brett Hewlett Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 0.25 % which means that it generated profit of $0.25 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of 6.64 % meaning that it generated $6.64 on every $100 dollars invested by stockholders.
The company has accumulated 63.4 M in total debt with debt to equity ratio (D/E) of 46.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Comvita Limited has Current Ratio of 7.87 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Entity Summary

Comvita Limited manufactures and markets natural health products. Comvita Limited was founded in 1974 and is headquartered in Te Puke, New Zealand. Comvita Limited operates under Drug Manufacturers - Specialty Generic classification in USA and traded on OTC Market.Comvita Limited (CVNZF) is traded on OTC Market in USA. It is located in 23 Wilson Road South and employs 500 people.

Comvita Limited Leadership Team

Sarah Ottrey, Director
Simon Pothecary, Executive
Ben Shaw, Executive
Paul Reid, Director
Roy Ong, Executive
Patrick Brus, Executive
Alan Bougen, Chairman
Maurice Prendergast, Director
Scott Coulter, CEO
Lucas Bunt, Director
Murray Denyer, Director
Sharon Hollenstein, Executive
Brett Hewlett, CEO
Julianne Keast, CFO
Mark Sadd, Executive
Thomas Cullwick, Director
Neil Craig, Chairman
Kate Selway, Executive
Edward Quilty, Director
RalfChristian Schlothauer, Executive
MBA DipT, Executive
Sarah Kennedy, Director
Colin Baskin, Executive
Julie Chadwick, Executive

Stock Performance Indicators

Current Sentiment - CVNZF

Comvita Limited Investor Sentiment
Macroaxis portfolio users are unresponsive in their opinion about investing in Comvita Limited. What is your opinion about investing in Comvita Limited? Are you bullish or bearish?
50% Bullish
50% Bearish

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Comvita and U S Bancorp. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.